The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ananta Medicare Ltd
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ananta Medicare Ltd, along with Rajesh Jain and Pradeep Kumar Jain (persons acting in concert), has acquired a 95% stake (2,37,50,000 shares) in Cian Healthcare Ltd via a Board-approved allotment on March 16, 2026. The acquisition involved 1.37 crore shares allotted at face value of INR 10, totalling INR 13.75 crore, to Ananta Medicare Ltd alone. Before this transaction, all three acquirers held zero shares in the company. This change of control follows a Resolution Plan approved by the NCLT Mumbai Bench on December 18, 2025, under the Insolvency and Bankruptcy Code, with Mr. Pradeep Kumar Jain named as the successful resolution applicant. The transaction qualifies for exemption from an open offer under Regulation 10(1)(da) of the SEBI Takeover Regulations.
For existing shareholders, this is effectively a change of control with new promoters taking 95% ownership through the IBC resolution process — existing public shareholders now hold only about 5%, and the stock is likely to see a sharp re-rating or continued volatility based on the new management's plans. Minority shareholders have limited say as the acquirers are exempt from making a mandatory open offer.